Xtant Medical Holdings, Inc.

AMEX:XTNT

Medical - Devices

Healthcare
$0.36 -0.16%

-$0.00 today

Market cap
$50.37M
Beta
-0.17
P/E (TTM)
33.4
EPS (TTM)
$0.01
52W Low $0.40High $0.95

Volume 0.16M

Average 0.16M

XTNT Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Xtant Medical Holdings, Inc.AMEX: XTNT

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 141.6% from a year ago

Cash & equivalents stood at $12.16M at the end of Q1 FY2026, up 141.6% from a year earlier and down 28.7% from the prior quarter. Over 3 fiscal years it compounded at -5.6% a year.

Context

  • Cash & equivalents amounted to 15.6% of total assets at the end of Q1 FY2026, up 10.3 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +141.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$12.16M-28.7% QoQ
Last fiscal yearDec 2025
$17.05M+175.1% YoY
Year agoMar 2025
$5.03M+141.6% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+141.6%——
1 year+175.1%——
3-year CAGR-5.6%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
17.05M USD
Year-over-year change
+175.1%
4-year CAGR
-1.7%

Cash & Equivalents vs competitors

How XTNT compares with its peers on the latest reported figures

  • XTNT's Mar 2026 cash & equivalents of $12.16M is the 6th highest of the 8 companies compared; the peer median is $19.75M.
  • Its year-over-year change of +141.6% is the highest of 8, against a peer median of -1.1%.
  • Cash & equivalents amounts to 15.6% of total assets for XTNT, versus a peer median of 35.9%.
XTNT Competitors Peer median
Cash & Equivalents for XTNT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
FONRFONAR CorporationMar 2026$53.65M -1.1%+5.0%24.5%
APYXApyx Medical CorporationMar 2026$31.14M +0.4%+46.0%49.4%
LUCDLucid Diagnostics Inc.Mar 2026$27.88M +10.5%+15.6%81.8%
VANIVivani Medical, Inc.Mar 2026$19.75M +51.8%-28.9%46.6%
RPIDRapid Micro Biosystems, Inc.Mar 2026$13.82M -26.9%-9.5%22.2%
XTNTXtant Medical Holdings, Inc.Mar 2026$12.16M +141.6%-5.6%15.6%
RCELAVITA Medical, Inc.Mar 2026$8.31M -44.1%-17.4%16.1%
EXOZeXoZymes, Inc.Mar 2026$1.44M -83.0%+75.9%35.9%
Peer median (excluding XTNT) $19.75M-1.1%+5.0%35.9%

Competitors are the stored peer set for XTNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents18.24M20.3M5.72M6.2M17.05M
Short-term Investments00000
Net Receivables7.15M10.85M20.73M20.66M17.8M
Inventory17.95M17.29M36.89M38.63M30.26M
Other Current Assets144K882K1.54M1.62M13.13M
Total Current Assets44.33M49.32M64.87M67.12M78.25M
Property, Plant & Equipment (Net)6.47M7.17M10.22M10.96M9.39M
Goodwill3.21M3.21M7.3M7.3M6.07M
Intangible Assets400K344K10.09M8.36M299K
Long-term Investments00000
Tax Assets00000
Other Non-current Assets287K197K141K103K133K
Total Non-current Assets10.36M10.91M27.74M26.72M15.9M
Total Assets54.69M60.23M92.61M93.84M94.15M
Account Payables2.62M3.49M7.05M7.92M3.84M
Short-term Debt3.62M5.71M4.62M12.12M14.36M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities3.18M4.46M05.57M0
Total Current Liabilities11.08M15.22M22.99M28.58M29.48M
Long-term Debt11.79M9.69M17.17M22.04M11.03M
Deferred Tax Liabilities0021K42K5K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00210K00
Total Non-current Liabilities12.73M10.84M18.27M22.29M13.71M
Total Liabilities23.81M26.06M41.26M50.87M43.19M
Common Stock00000
Retained Earnings(235.19M)(243.67M)(243.01M)(259.46M)(254.49M)
Accumulated OCI0029K(316K)0
Other Stockholders Equity00000
Minority Interest00000
Total Equity30.88M34.17M51.35M42.96M50.95M
Total Debt16.85M17.07M23.56M35.14M28.72M
Net Debt(1.4M)(3.23M)17.84M28.94M11.66M

Xtant Medical Holdings, Inc.

AMEX:XTNT

Intrinsic Alpha fair value

Locked

Current Price

$0.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.